MedPath

Corneal Epithelial Wound Healing Difference Between Human Autoserum and Cord Blood Serum

Completed
Conditions
Corneal Epithelial Wound Healing
Registration Number
NCT00681642
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Human serum eye drops have been successfully used in the treatment of severe ocular surface disorders and the enhancement of corneal wound healing. Umbilical cord serum is also proven to be effective in treatment of dry eye and persistent corneal epithelial defects. However, there are limited studies comparing the corneal epithelial wound healing promoting effects between these two blood derived products. The purpose of this study is to test the corneal epithelial wound healing promoting effects between auto serum and human cord blood serum. Primary cultured bovine corneal epithelial cells were used as the model to investigate wound healing, cell proliferation and migration by means of scratch corneal wound healing assay evaluation, MTS assay and Boyden chamber migration assay in response to human serum and umbilical cord serum. The concentrations of EGF, TGF-β1, and fibronectin were also compared between human serum and umbilical cord serum with ELISA kits.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Healthy pregnant women
  • Cesarean section for labor
  • Complete placenta with umbilical cord retained
  • Healthy individual
Read More
Exclusion Criteria
  • The retained placenta and umbilical cord were not complete
  • Individual with anemia or other hematologic disorder unsuitable for blood donation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cell proliferation1 week
Secondary Outcome Measures
NameTimeMethod
Cell migration1 week

Trial Locations

Locations (1)

National Taiwan University Hospital, department of Ophthalmology

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath